Archive for Medication updates
Category M Crunch – Again!
The Quarter 1 2022/23 Category M prices show a mixed bag of price increases and price reductions. Additions: Acamprosate 333mg gastro-resistant tablets Fludrocortisone 100microgram tablets Melatonin 2mg modified-release tablets Deletions:...
Generics Costing More Than Tariff-April 2022
Each month over 140 generics, as priced in the Drug Tariff or DM+D, are priced at a lower price than the purchase price. When you take the clawback into account,...
Parallel Import Profitability – April 2022 Update!
We have updated the Parallel Import Profitability tool with the latest April prices!! Dispex Member can access to our Profitability Tools online. We provide everything you need to help you to...
New Dispensing Fee scale April 2022
The new Dispensing Fee Scale from 1 April 2022 has an average 27 pence increase per item compared to the October 21 to March 22 Fee Scale. This however is...
March 2022 Final Price Concessions Update
Source: NHSBSA / DHSC Drug Tariff News – March Part VIIIA reimbursement prices (issued 31 March) The Department of Health and Social Care has agreed the March Drug Tariff Part VIIIA reimbursement prices...
National Patient Safety Alert: Philips Health Systems V60, V60 Plus and V680 ventilators: potential unexpected shutdown leading to complete loss of ventilation (NatPSA/2022/002/MHRA)
Source: MHRA / Gov.uk 29.3.22 Philips Health Systems informed have identified an important safety issue due to potential unexpected shutdowns of all of their V60 and V60 Plus non-invasive ventilators....
Class 2 Medicines Recall: Pfizer Limited, Accuretic 10/12.5 mg film-coated tablets, EL (22)A/16
Source: MHRA / Gov.uk 23.3.22 Pfizer Ltd are recalling batch number DD4842 as a precautionary measure due to the identification of a nitrosamine above the acceptable limit. Company name Pfizer...
Updated Hayfever Formulary
By Dr Philip Koopowitz- Dispex In preparation for the runny nose, sneezes and irritated eyes, I have looked at the current common treatments available. Whilst patients are encouraged to self-medicate,...
Class 4 Medicines Defect Information: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder and solvent for suspension for injection, EL (22)A/15
Source: MHRA / Gov.uk 17.3.22 Brancaster Pharma Limited have notified us of an issue relating to the label of the Water for Injections (solvent) packaged in each finished product pack....
Company led medicines recall: Advanced Accelerator Applications NETSPOT (Kit for the preparation of gallium Ga 68 dotatate injection) [unlicensed medicine], CLMR (22)A/02
Source: MHRA / Gov.uk 16.3.22 Advanced Accelerator Applications is recalling specific batches of this product as a precautionary measure due to an out of specification result that was identified during...
Class 4 Medicines Defect Information, Ayrton Saunders Limited, Beclometasone dipropionate 50 micrograms/dose Nasal Spray (Various Liveries), EL (22)A/14
Source: MHRA/ Gov.uk 15.3.22 Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons. MDR Number MDR 087-03/22 Company name Ayrton Saunders Limited Product description...
Class 4 Medicines Defect Information: CNX Therapeutics Ltd, Latuda film-coated tablets, EL (22)A/13
Source: MHRA / Gov.uk 14.3.22 CNX Therapeutics Ltd. have notified the MHRA that the batches of Latuda film-coated tablets listed in this notification will be released without EAN barcodes on...
